Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Polano

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Cancers|March 13, 2025
Development of Clinical-Radiomics Nomogram for Predicting Post-Surgery Functional Improvement in High-Grade Glioma PatientsTamara Ius, Maurizio Polano, Michele Dal Bo, et al.
Biomolecules|May 28, 2025
Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD AssessmentGiovanni Luca Scaglione, Valentina Lombardo, Maurizio Polano, et al.
Cancers|October 18, 2019
A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine LearningMaurizio Polano, Marco Chierici, Michele Dal Bo, et al.
The Journal of Pathology|November 27, 2015
Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GISTMonica Brenca, Sabrina Rossi, Maurizio Polano, et al.
Journal of Clinical Medicine|January 10, 2026
Molecular Characterization of Adult-Type Lower-Grade Glioma (WHO Grade 1-3) with Targeted Next-Generation Sequencing: A Retrospective, Single-Institution ExperienceMaurizio Pinamonti, Maurizio Polano, Giacomo Cester, et al.
Cells|April 3, 2021
A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive StateMaurizio Polano, Emanuele Fabbiani, Eva Adreuzzi, et al.
Plos Genetics|April 19, 2017
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressivenessEros Di Giorgio, Elisa Franforte, Sebastiano Cefalù, et al.
Neuro-Oncology|September 9, 2021
The benefit of early surgery on overall survival in incidental low-grade glioma patients: A multicenter studyTamara Ius, Sam Ng, Jacob S Young, et al.
Nanomedicine (London, England)|January 15, 2025
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinomaMonica Mossenta, Monica Argenziano, Sara Capolla, et al.
Journal of Translational Medicine|July 7, 2023
Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resectionMichele Dal Bo, Maurizio Polano, Tamara Ius, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Cancers|March 13, 2025
Development of Clinical-Radiomics Nomogram for Predicting Post-Surgery Functional Improvement in High-Grade Glioma PatientsTamara Ius, Maurizio Polano, Michele Dal Bo, et al.
Biomolecules|May 28, 2025
Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD AssessmentGiovanni Luca Scaglione, Valentina Lombardo, Maurizio Polano, et al.
Cancers|October 18, 2019
A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine LearningMaurizio Polano, Marco Chierici, Michele Dal Bo, et al.
The Journal of Pathology|November 27, 2015
Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GISTMonica Brenca, Sabrina Rossi, Maurizio Polano, et al.
Journal of Clinical Medicine|January 10, 2026
Molecular Characterization of Adult-Type Lower-Grade Glioma (WHO Grade 1-3) with Targeted Next-Generation Sequencing: A Retrospective, Single-Institution ExperienceMaurizio Pinamonti, Maurizio Polano, Giacomo Cester, et al.
Cells|April 3, 2021
A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive StateMaurizio Polano, Emanuele Fabbiani, Eva Adreuzzi, et al.
Plos Genetics|April 19, 2017
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressivenessEros Di Giorgio, Elisa Franforte, Sebastiano Cefalù, et al.
Neuro-Oncology|September 9, 2021
The benefit of early surgery on overall survival in incidental low-grade glioma patients: A multicenter studyTamara Ius, Sam Ng, Jacob S Young, et al.
Nanomedicine (London, England)|January 15, 2025
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinomaMonica Mossenta, Monica Argenziano, Sara Capolla, et al.
Journal of Translational Medicine|July 7, 2023
Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resectionMichele Dal Bo, Maurizio Polano, Tamara Ius, et al.
Pageof 4